Neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review

被引:2
作者
Rice-Canetto, Tyler E. [1 ,2 ]
Joshi, Sonali J. [1 ,2 ]
Kyan, Katie A. [1 ,2 ]
Siddiqi, Javed [1 ,2 ,3 ,4 ]
机构
[1] Calif Univ Sci & Med, Neurosurg, Colton, CA 92324 USA
[2] Arrowhead Reg Med Ctr, Neurosurg, Colton, CA 92324 USA
[3] Desert Reg Med Ctr, Neurosurg, Palm Springs, CA USA
[4] Riverside Univ Hlth Syst, Med Ctr, Neurosurg, Moreno Valley, CA USA
关键词
cognitive dysfunction; status epilepticus (se); transverse myelitis; auto immune; neurology and psychiatric disorders; american college of rheumatology (acr); systemic lupus erythematosus; neuropsychiatric systemic lupus erythematosus (npsle);
D O I
10.7759/cureus.61678
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neuropsychiatric systemic lupus erythematosus (NPSLE) refers to the neurological and psychiatric manifestations of systemic lupus erythematosus (SLE), which remain poorly understood yet often have a profound effect on the lives of afflicted patients. The aim of this study is to synthesize the available information on the pathogenesis, diagnostics, management, and prognosis of this disease. Our hope is to increase awareness and call for further investigations that may optimize NPSLE patient outcomes and quality of life. We performed a literature review following the Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines, resulting in 11 studies of inclusion. Within each study, we extracted data on epidemiologic factors, diagnostics, therapeutic modalities, and prognosis for each neuropsychiatric condition. The most widely discussed neuropsychiatric manifestations of SLE based on the American College of Rheumatology (ACR) classifications included status epilepticus (SE) and seizures, transverse myelitis (TM), and cognitive dysfunction. SE and TM had a prevalence of 1-2%, while cognitive dysfunction was nearly 38%. Diagnostics varied depending on symptom presentation but often included brain magnetic resonance imaging (MRI) and antibody testing. Treatment for NPSLE is still widely understudied, but concurrent treatment with immunosuppressants and anti-inflammatories for symptom control and more targeted immunotherapies based on the specific condition is often effective. Prognosis is highly symptom dependent, ranging from a 12.5% one-year mortality in SE and seizure patients to near resolution of symptoms in certain presentations including idiopathic intracranial hypertension and cerebellar ataxia. Further studies are needed to better understand the pathophysiology, diagnostics, and effective therapeutic measures for NPSLE. The severity of these manifestations and generally poor prognosis highlight the need for more research to accurately diagnose and treat this disease. While there is still little data available, this literature review serves to provide updated context on this condition.
引用
收藏
页数:10
相关论文
共 22 条
  • [1] What is the prevalence of cognitive impairment in lupus and which instruments are used to measure it? A systematic review and meta-analysis
    Al Rayes, Hanan
    Tani, Chiara
    Kwan, Andrew
    Marzouk, Sherief
    Colosimo, Kenneth
    Medina-Rosas, Jorge
    Mustafa, Ahmed
    Su, Jiandong
    Lambiris, Panos
    Mosca, Marta
    Touma, Zahi
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2018, 48 (02) : 240 - 255
  • [2] Neuropsychiatric involvement in systemic lupus erythematosus: A review
    Carrion-Barbera, Irene
    Carlos Salman-Monte, Tarek
    Vilchez-Oya, F.
    Monfort, Jordi
    [J]. AUTOIMMUNITY REVIEWS, 2021, 20 (04)
  • [3] Immunosuppressive therapy of systemic lupus erythematosus associated peripheral neuropathy: A systematic review
    Constantin, Alexandru
    Nastase, Daniela
    Tulba, Delia
    Balanescu, Paul
    Baicus, Cristian
    [J]. LUPUS, 2020, 29 (12) : 1509 - 1519
  • [4] EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
    Fanouriakis, Antonis
    Kostopoulou, Myrto
    Andersen, Jeanette
    Aringer, Martin
    Arnaud, Laurent
    Bae, Sang-Cheol
    Boletis, John
    Bruce, Ian N.
    Cervera, Ricard
    Doria, Andrea
    Doerner, Thomas
    Furie, Richard A.
    Gladman, Dafna D.
    Houssiau, Frederic A.
    Ines, Luis Sousa
    Jayne, David
    Kouloumas, Marios
    Kovacs, Laszlo
    Mok, Chi Chiu
    Morand, Eric F.
    Moroni, Gabriella
    Mosca, Marta
    Mucke, Johanna
    Mukhtyar, Chetan B.
    Nagy, Gyoergy
    Navarra, Sandra
    Parodis, Ioannis
    Pego-Reigosa, Jose M.
    Petri, Michelle
    Pons-Estel, Bernardo A.
    Schneider, Matthias
    Smolen, Josef S.
    Svenungsson, Elisabet
    Tanaka, Yoshiya
    Tektonidou, Maria G.
    Teng, Y. K. Onno
    Tincani, Angela
    Vital, Edward M.
    van Vollenhoven, Ronald F.
    Wincup, Chris
    Bertsias, George
    Boumpas, Dimitrios T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (01) : 15 - 29
  • [5] Prevalence of neuropsychiatric disorders in patients with systemic lupus erythematosus in Pakistan: A systematic review and meta-analysis
    Khan, Muhammad Imran
    Qureshi, Humera
    Akhtar, Sohail
    Bae, Suk Joo
    Hassan, Fazal
    [J]. FRONTIERS IN PSYCHIATRY, 2023, 14
  • [7] Neuro-psychiatric manifestations in patients with systemic lupus erythematosus: A systematic review and results from the Swiss lupus cohort study
    Meier, Aline L.
    Bodmer, Nicolas S.
    Wirth, Carla
    Bachmann, Lucas M.
    Ribi, Camillo
    Probstel, Anne-Katrin
    Waeber, David
    Jelcic, Ilijas
    Steiner, Urs C.
    [J]. LUPUS, 2021, 30 (10) : 1565 - 1576
  • [8] Long-term outcome of status epilepticus-related to systemic lupus erythematosus: An observational study and a systematic review
    Mikdashi, Jamal
    Krumholz, Allan
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2023, 63
  • [9] Altered functional neuronal activity in neuropsychiatric lupus: A systematic review of the fMRI investigations
    Mikdashi, Jamal A.
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2016, 45 (04) : 455 - 462
  • [10] Cognitive dysfunction in SLE: An understudied clinical manifestation
    Mizrachi, Mark
    Anderson, Erik
    Carroll, Kaitlin R.
    Tehrani, Nazila
    Volpe, Bruce T.
    Diamond, Betty
    [J]. JOURNAL OF AUTOIMMUNITY, 2022, 132